Overview Financials News + Filings Key Docs Charts Ownership Insiders
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Quarterly results
Director departure
|
|
F-star Therapeutics, Inc. (SBPH)
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 03/20/2023 |
15-12G
| Form 15-12G - Securities registration termination [Section 12(g)]: |
| 03/17/2023 |
SC 13G
| Beryl Capital Management LLC reports a 0% stake in F-Star Therapeutics, Inc. |
| 03/14/2023 |
EFFECT
| Form EFFECT - Notice of Effectiveness: |
| 03/14/2023 |
EFFECT
| Form EFFECT - Notice of Effectiveness: |
| 03/14/2023 |
EFFECT
| Form EFFECT - Notice of Effectiveness: |
| 03/14/2023 |
EFFECT
| Form EFFECT - Notice of Effectiveness: |
| 03/14/2023 |
EFFECT
| Form EFFECT - Notice of Effectiveness: |
| 03/09/2023 |
4
| Kayitalire Louis (CHIEF MEDICAL OFFICER) has filed a Form 4 on F-star Therapeutics, Inc.|
Txns:
| Unknown transaction of 29,236 shares
@ $7.12, valued at
$208.2k
Disposed/sold 25,019 shares
@ $7.12, valued at
$178.1k
Disposed/sold 27,289 options to buy
@ $16.62, valued at
$453.5k
Disposed/sold 12,880 options to buy
@ $7.24, valued at
$93.3k
Disposed/sold 53,634 options to buy
@ $4.77, valued at
$255.8k
Disposed/sold 35,719 options to buy
@ $3.55, valued at
$126.8k
|
|
| 03/09/2023 |
4
| Forster Eliot (PRESIDENT AND CEO) has filed a Form 4 on F-star Therapeutics, Inc.|
Txns:
| Unknown transaction of 347,578 shares
@ $7.12, valued at
$2.5M
Disposed/sold 73,959 shares
@ $7.12, valued at
$526.6k
Disposed/sold 127,924 options to buy
@ $7.24, valued at
$926.2k
Disposed/sold 165,028 options to buy
@ $4.77, valued at
$787.2k
Disposed/sold 126,909 options to buy
@ $3.55, valued at
$450.5k
|
|
| 03/09/2023 |
4
| Klein Pamela M. (Director) has filed a Form 4 on F-star Therapeutics, Inc.|
Txns:
| Disposed/sold 20,000 options to buy
@ $6.88, valued at
$137.6k
Disposed/sold 20,000 options to buy
@ $3.41, valued at
$68.2k
Disposed of 15,000 options to buy
@ $4.62, valued at
$69.3k
Disposed of 7,500 options to buy
@ $1.6, valued at
$12k
|
|
| 03/09/2023 |
4
| DEPTULA-HICKS DARLENE M (See Remarks) has filed a Form 4 on F-star Therapeutics, Inc.|
Txns:
| Unknown transaction of 30,898 shares
@ $7.12, valued at
$220k
Disposed/sold 25,539 shares
@ $7.12, valued at
$181.8k
Disposed/sold 28,426 options to buy
@ $16.62, valued at
$472.4k
Disposed/sold 25,894 options to buy
@ $7.34, valued at
$190.1k
Disposed/sold 59,823 options to buy
@ $4.77, valued at
$285.4k
Disposed/sold 24,902 options to buy
@ $3.55, valued at
$88.4k
|
|
| 03/09/2023 |
4
| Brady Todd C (Director) has filed a Form 4 on F-star Therapeutics, Inc.|
Txns:
| Unknown transaction of 15,004 shares
@ $7.12, valued at
$106.8k
Disposed/sold 20,000 options to buy
@ $6.88, valued at
$137.6k
Disposed/sold 20,000 options to buy
@ $3.41, valued at
$68.2k
Disposed of 11,000 options to buy
@ $9.05, valued at
$99.6k
Disposed of 10,964 warrants
@ $10.79, valued at
$118.3k
Disposed of 5,500 options to buy
@ $14.27, valued at
$78.5k
Disposed of 5,500 options to buy
@ $13.99, valued at
$76.9k
Disposed of 7,500 options to buy
@ $4.62, valued at
$34.7k
Disposed of 7,500 options to buy
@ $1.6, valued at
$12k
|
|
| 03/09/2023 |
4
| Brewis Neil (CHIEF SCIENTIFIC OFFICER) has filed a Form 4 on F-star Therapeutics, Inc.|
Txns:
| Unknown transaction of 105,088 shares
@ $7.12, valued at
$748.2k
Disposed/sold 9,375 shares
@ $7.12, valued at
$66.8k
Disposed/sold 22,561 options to buy
@ $7.24, valued at
$163.3k
Disposed/sold 74,263 options to buy
@ $4.77, valued at
$354.2k
Disposed/sold 132,469 options to buy
@ $3.55, valued at
$470.3k
|
|
| 03/09/2023 |
4
| Race Geoffrey (Director) has filed a Form 4 on F-star Therapeutics, Inc.|
Txns:
| Unknown transaction of 3,937 shares
@ $7.12, valued at
$28k
Disposed/sold 20,000 options to buy
@ $6.88, valued at
$137.6k
Disposed/sold 20,000 options to buy
@ $3.41, valued at
$68.2k
|
|
| 03/09/2023 |
4
| Bermingham Nessan (Director) has filed a Form 4 on F-star Therapeutics, Inc.|
Txns:
| Unknown transaction of 97,547 shares
@ $7.12, valued at
$694.5k
Disposed/sold 6,328 shares
@ $7.12, valued at
$45.1k
Disposed/sold 34,111 options to buy
@ $16.62, valued at
$566.9k
Disposed/sold 20,000 options to buy
@ $6.88, valued at
$137.6k
Disposed/sold 20,000 options to buy
@ $3.41, valued at
$68.2k
|
|
| 03/09/2023 |
4
| Benz Edward JR (Director) has filed a Form 4 on F-star Therapeutics, Inc.|
Txns:
| Disposed/sold 4,385 shares
@ $7.12, valued at
$31.2k
Disposed/sold 3,937 options to buy
@ $14.31, valued at
$56.3k
Disposed/sold 20,000 options to buy
@ $6.88, valued at
$137.6k
Disposed/sold 20,000 options to buy
@ $3.41, valued at
$68.2k
|
|
| 03/09/2023 |
4
| Arkowitz David (Director) has filed a Form 4 on F-star Therapeutics, Inc.|
Txns:
| Unknown transaction of 8,386 shares
@ $7.12, valued at
$59.7k
Disposed/sold 20,000 options to buy
@ $6.88, valued at
$137.6k
Disposed/sold 20,000 options to buy
@ $3.41, valued at
$68.2k
Disposed of 10,000 options to buy
@ $9.28, valued at
$92.8k
Disposed of 5,500 options to buy
@ $9.05, valued at
$49.8k
Disposed of 4,386 warrants
@ $10.79, valued at
$47.3k
Disposed of 5,500 options to buy
@ $14.27, valued at
$78.5k
Disposed of 5,500 options to buy
@ $13.99, valued at
$76.9k
Disposed of 7,500 options to buy
@ $4.62, valued at
$34.7k
Disposed of 7,500 options to buy
@ $1.6, valued at
$12k
|
|
| 03/09/2023 |
S-8 POS
| Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments: |
| 03/09/2023 |
S-8 POS
| Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments: |
| 03/09/2023 |
S-8 POS
| Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments: |
| 03/09/2023 |
S-8 POS
| Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments: |
| 03/09/2023 |
S-8 POS
| Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments: |
| 03/09/2023 |
S-8 POS
| Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments: |
| 03/09/2023 |
POS AM
| Form POS AM - Post-Effective amendments for registration statement: |
| 03/09/2023 |
POS AM
| Form POS AM - Post-Effective amendments for registration statement: |
| 03/09/2023 |
POS AM
| Form POS AM - Post-Effective amendments for registration statement: |
| 03/09/2023 |
POS AM
| Form POS AM - Post-Effective amendments for registration statement: |
| 03/09/2023 |
POS AM
| Form POS AM - Post-Effective amendments for registration statement: |
| 03/09/2023 |
8-K
| Completion of Acquisition or Disposition of Assets, Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Sta... |
| 03/09/2023 |
SC 14D9/A
| Form SC 14D9/A - Solicitation, recommendation statements: [Amend] |
| 03/09/2023 |
25-NSE
| Form 25-NSE - Notification filed by national security exchange to report the removal from listing and registration of matured, redeemed or retired securities: |
| 03/09/2023 |
SC TO-T/A
| Form SC TO-T/A - Tender offer statement by Third Party: [Amend] |
| 03/07/2023 |
SC 14D9/A
| Form SC 14D9/A - Solicitation, recommendation statements: [Amend] |
| 03/07/2023 |
SC TO-T/A
| Form SC TO-T/A - Tender offer statement by Third Party: [Amend] |
|
|
|